Antares Pharma (ATRS)
5.59 unch (unch) 05/24/22 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Mon, May 23rd, 2022
Results
download Want to compare other data? Select FieldsSymbol | ATRS | CNMD | STAA | ||
Company | Antares Pharma | C O N M E D Corp | Staar Surgical Company | ||
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | ||
Open | 5.58 | 51.05 | 18.25 | ||
High | 5.60 | 51.05 | 18.44 | ||
Low | 5.58 | 48.39 | 17.72 | ||
Last | 5.59 | 49.11 | 18.26 | ||
Change | unch | -2.06 | -0.28 | ||
% Change | unch | -4.03% | -1.51% | ||
Volume | 2,707,400 | 610,600 | 627,000 | ||
20-Day Average Volume | 3,885,230 | 591,800 | 920,760 | ||
Previous Close | 5.59 | 51.17 | 18.54 | ||
Industry | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 5.57 | 51.85 | 16.96 | ||
20-Day Raw Stochastic | 83.33% | 20.56% | 87.71% | ||
20-Day Relative Strength | 76.57% | 37.95% | 52.96% | ||
Weighted Alpha | +30.00 | -37.86 | -53.04 | ||
Today's Opinion | 100% Buy | 100% Sell | 56% Sell | ||
Previous Opinion | 100% Buy | 100% Sell | 56% Sell | ||
Last Month's Opinion | 88% Buy | 88% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.36% since 05/16/22 | -1.21% since 04/23/25 | +4.94% since 04/23/25 | ||
Low | 5.57 on 05/18/22 | 48.39 on 04/30/25 | 17.31 on 04/24/25 | ||
High | 5.60 on 05/23/22 | 51.89 on 04/29/25 | 18.76 on 04/29/25 | ||
1-Month | |||||
%Chg | +0.36% since 04/22/22 | -16.55% since 03/28/25 | +2.64% since 03/28/25 | ||
Low | 5.54 on 05/12/22 | 46.00 on 04/21/25 | 14.69 on 04/09/25 | ||
High | 5.60 on 05/23/22 | 61.13 on 04/02/25 | 18.76 on 04/29/25 | ||
3-Month | |||||
%Chg | +65.88% since 02/23/22 | -30.69% since 01/30/25 | -23.82% since 01/30/25 | ||
Low | 3.24 on 02/24/22 | 46.00 on 04/21/25 | 13.50 on 02/12/25 | ||
High | 5.60 on 05/23/22 | 74.70 on 02/05/25 | 24.50 on 01/31/25 | ||
6-Month | |||||
%Chg | +63.93% since 11/23/21 | -24.75% since 10/30/24 | -38.08% since 10/30/24 | ||
Low | 3.11 on 01/28/22 | 46.00 on 04/21/25 | 13.50 on 02/12/25 | ||
High | 5.60 on 05/23/22 | 78.00 on 11/25/24 | 32.00 on 11/07/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 955,063 | 1,582,688 | 918,212 | ||
Shares Outstanding, K | 170,852 | 30,930 | 49,526 | ||
Annual Sales | 183,980,000 | 1,307,020,000 | 313,900,000 | ||
Annual Net Income | 46,290,000 | 132,420,000 | -20,210,000 | ||
Last Quarter Sales | 41,560,000 | 345,940,000 | 48,950,000 | ||
Last Quarter Net Income | -2,320,000 | 33,750,000 | -34,230,000 | ||
60-Month Beta | 1.15 | 1.28 | 0.75 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.01 on 05/10/22 | 1.34 on 02/05/25 | -0.50 on 02/11/25 | ||
Latest Earnings Date | 05/19/22 | 04/30/25 | 05/07/25 | ||
Most Recent Dividend | N/A | 0.200 on 03/14/25 | N/A | ||
Next Ex-Dividends Date | N/A | 03/14/25 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 79.86 | 12.22 | 0.00 |